Item Infomation
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yuki, Kotani | - |
| dc.contributor.author | Annamaria Di, Gioia | - |
| dc.contributor.author | Giovanni, Landoni | - |
| dc.date.accessioned | 2023-03-28T06:49:35Z | - |
| dc.date.available | 2023-03-28T06:49:35Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s13054-023-04322-y | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/7223 | - |
| dc.description | CC BY | vi |
| dc.description.abstract | Vasopressors and fluids are the cornerstones for the treatment of shock. The current international guidelines on shock recommend norepinephrine as the first-line vasopressor and vasopressin as the second-line vasopressor. In clinical practice, due to drug availability, local practice variations, special settings, and ongoing research, several alternative vasoconstrictors and adjuncts are used in the absence of precise equivalent doses. Norepinephrine equivalence (NEE) is frequently used in clinical trials to overcome this heterogeneity and describe vasopressor support in a standardized manner. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | Norepinephrine equivalence | vi |
| dc.subject | Vasopressors | vi |
| dc.title | An updated “norepinephrine equivalent” score in intensive care as a marker of shock severity | vi |
| dc.type | Book | vi |
| Appears in Collections | OER- Y học- Điều dưỡng | |
Files in This Item:
